Aura Biosciences Announces Proposed Public Offering of Common Stock
06.11.2023 - Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the launch of an underwritten public ... Seite 1